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Introduction
The formation of a complex network of neurons during the development of the nervous system is based on specific interactions amongst neurons and between neurons and their environment. These interactions are likely to be mediated by surface glycoproteins present on the axons' leading tip, the growth cone, acting as specific recognition molecules to guide axons to their targets (Patterson, 1992; Goodman and Shatz, 1993) . Among the presently known molecules considered to be involved in axon guidance, neural surface glycoproteins of the immunoglobulin (Ig) superfamily play a prominent role. These have been categorized into molecules composed of Ig domains only or of Ig domains in conjunction with fibronectin type III (FNIII) domains (Rathjen and Jessell, 1991) . Based on structural criteria, i.e. membrane anchorage and particular combinations of Ig and FNIII domains, the family of Ig/ FNIII neural glycoproteins can be divided further into several subgroups (Vielmetter et al., 1994) . The glycosylphosphatidylinositol (GPI)-anchored proteins contactin/ F 11/F3, TAG-1/axonin-1, PANG/BIG-I and BIG-2 constitute one such subgroup and are striking particularly in their spatially and temporally restricted patterns of expression during neuronal development (Ranscht, 1988; Brummendorf et al., 1989; Gennarini et al., 1989; Furley et al., 1990; Zuellig et al., 1992; Connelly et al., 1994; Yoshihara et al., 1994 Yoshihara et al., , 1995 . They are composed of six Ig and four FNIII domains separated by a glycine/prolinerich segment. Their modular assembly suggests that the GPI-anchored Ig/FNIII neural glycoproteins regulate axonal elongation along specific pathways by multiple macromolecular interactions (Sonderegger and Rathjen, 1992) , and, indeed, several specific binding activities have now been demonstrated in vitro (Brummendorf and Rathjen, 1993) . Axonin-1 of the chick has been shown to bind homophilically (Rader et al., 1993) and heterophilically to neuron-glia cell adhesion molecule (NgCAM; Kuhn et al., 1991) and Ng-CAM-related cell adhesion molecule (NrCAM/Bravo; Suter et al., 1995) . Both NgCAM and NrCAM/Bravo belong to a subgroup of Igl FNIII neural glycoproteins which are composed of six Ig and five FNIII domains, a single transmembrane segment and a cytoplasmic tail (Burgoon et al., 1991; Grumet et al., 1991; Kayyem et al., 1992) . The recent description of axonin-1, NgCAM and NrCAM/Bravo as the molecules involved in the pathfinding decision of spinal commissural axons at the floor plate (Stoeckli and Landmesser, 1995) puts these molecules in the focus of current interest as one of the best described pathfinding models in vertebrates.
The interaction of axonin-1 and NgCAM was concluded to mediate the promotion of neurite outgrowth of chicken embryonic dorsal root ganglion neurons on axonin-1 substratum in vitro, as evidenced by the virtually complete arrest of neurite outgrowth in the presence of polyclonal antibodies directed to NgCAM (Kuhn et al., 1991) . To understand better the functional implications of this interaction, we have begun a detailed structure/function analysis of axonin-1-NgCAM binding. Here we report the identification of the NgCAM binding site on axonin-1 and propose a model for the domain arrangement of axonin-1. With this structure, membrane-bound axonin-1 may interact with NgCAM of the same membrane rather than with NgCAM of an apposed membrane. Thus, it is unlikely that NgCAM is the growth cone receptor for neurite outgrowth on axonin-1 substratum. Neurite outgrowth studies support this prediction.
Results
The deletion of the fifth and the sixth Ig domain of axonin-1 results in an increased binding of NgCAM Entire domains of axonin-1, as defined by their homology to the Ig constant domains or the type III domains of fibronectin (Zuellig et al., 1992) and by exon-intron borders of the axonin-l gene (Giger et al., 1995) , were deleted by oligonucleotide-directed mutagenesis and cloned into the axonin-1 expression vector pSCT-axonin-1. Vectors carrying these constructs were introduced into COS cells by electroporation. The transiently transfected cells were solubilized 2 days after transfection, and analysed for axonin-expression by immunoblotting. The sizes of the axonin-domain deletion mutants were in agreement with the predicted values ( Figure 1 ). No axonin-1 immunoreactivity was detectable on parental COS cells. Immunofluorescence analyses revealed that all mutants, except the one where the most amino-terminal Ig domain was deleted, designated AIgl, were expressed on the surface of COS cells in similar quantities to wildtype axonin-l (data not shown). AIgi, although apparently absent from the cell surface, was detected in similar quantities to wild-type axonin-1 when solubilized membranes were analysed by immunoblotting ( Figure IA ), suggesting that AIgl was produced but remained inside the cell. Treatment with phosphatidylinositol-specific phospholipase C revealed a GPI anchorage of axonin-1 heterologously expressed by COS cells (data not shown). Usually 20-30% of the cells expressed heterologous protein after transfection by electroporation. Two days after transfection, cells were incubated with NgCAMconjugated polystyrene microspheres (Covaspheres) and, after washing and fixation, axonin-1-expressing cells were identified by indirect immunofluorescence staining. An initial series of axonin-1 domain deletion mutants included the complete set of single domain deletions and three double domain deletions in the amino-proximal region ( Figure 2A ). The NgCAM binding properties of these mutants together with wild-type axonin-1 are summarized in Figure 2B . Surprisingly, wild-type axonin-1 expressed on the surface of COS cells was found to bind NgCAMconjugated Covaspheres only weakly. The same result was obtained with wild-type axonin-1 heterologously expressed on the surface of myeloma and fibroblasts cell lines (data not shown), and was in striking contrast to the results of Covaspheres aggregation assays where a strong interaction of native or recombinant axonin-1 and NgCAM had been detected with both binding partners covalently coupled to Covaspheres (Kuhn et al., 1991; Rader et al., 1993) . These findings suggested that the failure of recombinant membrane-bound axonin-1 to interact with NgCAM may not be ascribed to its heterologous expression but, probably, to a difference in the accessibility of the NgCAM binding site of axonin-1 when covalently coupled to Covaspheres compared with when membrane-bound. The NgCAM binding properties of the axonin-domain deletion mutants supported this view. Whereas cells expressing AIg 12, AIg2, AIg23, AIg3, AIg34, AIg4, AFn2 and AFn3 did not bind NgCAM-conjugated Covaspheres, transfectants expressing AIg5 and AIg6 exhibited a strongly increased NgCAM binding when compared with cells transfected with wild-type axonin-1 ( Figure 2B ). To a lesser degree, ) and COS cells transfected with wild-type axonin-1 ('wild-type recombinant') or domain deletion mutants of axonin-1 (for labels see Figure 2 ) were subjected to SDS-PAGE (7.5%), electrotransferred to nitrocellulose and immunostained with a mixture of four anti-axonin-1 mAbs followed by peroxidase-conjugated secondary antibodies. The epitopes of the four mAbs used for immunostaining had been mapped to sites beyond (A) or within (B) the four amino-terminal Ig domains of axonin-l. Vitreous fluid of 14-day-old chicken embryos ('wild-type native') was blotted for comparison. Numbers on the edge indicate the molecular masses of marker proteins in kDa.
AFn4 also was found to exhibit increased NgCAM binding. shaped structures, the uniform appearance suggesting little segmental flexibility. The size of each arm of the horseshoe was lOx4 nm and the distance between the arms was -5 nm (data not shown). As known from crystallographic data, the dimensions of a single Ig or FNIII domain arẽ 4X2.5X2 nm (Amzel and Poljak, 1979; Leahy et al., 1992) . Thus, the size of the horseshoe-shaped structures is large enough to comprise the 10 modules of one axonin-1 molecule, but too small to allow the interpretation of these structures as axonin-1 dimers. In addition, we proved by sedimentation equilibrium ultracentrifugation that soluble axonin-molecules do not form aggregates below a concentration of 10 mg/ml (data not shown), while the electron microscopy data are based on an axonin-1 concentration of 75 gg/ml. The horseshoe-shaped structure of axonin-as revealed by electron microscopy is in good agreement with the backfolded shape proposed on the basis of the NgCAM binding properties of the axonin-domain deletion mutants.
The four amino-terminal domains of axonin-1 form a domain conglomerate The whole of the four amino-terminal Ig domains was found to be required for NgCAM binding. As a result, deletion analyses within this region do not allow the localization of the actual binding site. To obtain independent data to extend this mapping analysis, a selection of 13 monoclonal antibodies (mAbs) directed to axonin-1 was included in the binding assays. Based on axonin-1 deletion mutants and indirect immunofluorescence analyses, eight mAbs, namely V3B3, X7F6, X7H5, X3G12, X7G9, V9H6, X9C12 and X9H8, had been mapped to the four amino-terminal Ig domains (Table I (Stoeckli et al., 1991) . The growth cone receptor for adsorbed axonin-1 was concluded to be NgCAM, based on the fact that neurite outgrowth on axonin-1 was blocked by NgCAM antiserum Fab (Kuhn et al., 1991 To address this point, we analysed the neurite outgrowth activity of native axonin-1 coated onto tissue culture plastic and presented as substratum for dissociated dorsal root ganglion neurons from 10-day-old chicken embryos in the presence of monovalent X9H8 antibody. As already shown, X9H8 was found to block the axonin-1-NgCAM interaction most potently. Although X9H8 Fab bound to adsorbed axonin-1 (data not shown), no perturbation of neurite outgrowth was detected ( Figure 8C and E). Moreover, no perturbation of neurite outgrowth was obtained for X7F6 Fab which is also expected to inhibit binding of neuronal NgCAM to adsorbed axonin-1 ( Figure 6A ; data not shown). In contrast, monovalent polyclonal antibodies directed to axonin-1 completely blocked neurite outgrowth on axonin-1 ( Figure 8E ) and, as a control, did not inhibit neurite outgrowth on laminin (data not shown). These results suggested that blocking the NgCAM binding site of adsorbed axonin-1 does not interfere with its neurite outgrowth-promoting activity.
In order to confirm this finding, neurite outgrowth was examined on three different axonin-1 variants produced in a myeloma-based expression system (Traunecker et al., 199 la) . Previously, we had demonstrated that recombinant axonin-1 generated by this system is highly similar to native axonin-1 with respect to both its structural and functional integrity (Rader et al., 1993) . Figure 8A ). The soluble axonin-1 variants were constitutively secreted by transfected J558L myeloma cells, immunoaffinity purified with an anti-C, mAb, and analysed by SDS-PAGE ( Figure   8B ). axonin-1 variants were coated onto tissue culture plastic and presented as substratum for dissociated dorsal root ganglion neurons from 10-day-old chicken embryos. While the number of neurons with neurites on wild-type-C, and AIg l234-C, was comparable with native axonin-1, Ig 1 234-CK was found to have strongly reduced outgrowthpromoting activity in the range of ovalbumin substratum ( Figure 8E ). Compared with native axonin-1, purified by the four-step chromatographic procedure established by Ruegg et al. (1989) , the neurite length on both wild-type-CK and AIgl234-CK was slightly lower (data not shown).
We also have observed a reduction of neurite length for immunoaffinity-purified native and recombinant axonin-1 and ascribe it to the relatively harsh conditions which have to be used for eluting proteins from immunoaffinity columns (Rader et al., 1993 ; data not shown). As for native axonin-1, neurite outgrowth on wild-type-C,r and AIgl 234-C, could be inhibited specifically by the presence of monovalent polyclonal antibodies directed to axonin-1, whereas addition of X9H8 Fab had no effect ( Figure 8E ). (Staunton et al., 1990; Diamond et al., 1991 (Brummendorf et al., 1993 (Figure 9 ). As a main feature of this model, the six Ig domains, including a conglomerate of the four amino-terminal Ig domains, fold back towards the membrane, possibly by means of the highly conserved glycine/proline-rich segment between the Ig and the FNIII moieties (Furley et al., 1990; Zuellig et al., 1992; Hasler et al., 1993) . Due to the backfolding, the amino-terminal domain conglomerate containing the NgCAM binding site becomes located close to the membrane-anchored carboxy-terminal domains and, thus, may be inaccessible for NgCAM exposed on the surface of another cell. Conversely, when axonin-1 is coupled randomly to microspheres, the NgCAM binding site is expected to be surface oriented in at least a fraction of the axonin-1 molecules (Figure 9 ), explaining the strong binding to NgCAM observed in these experiments (Kuhn et al., 1991; Rader et al., 1993) . Bulky and charged sugar residues located on the fifth and sixth domain might contribute to the inaccessibility of the NgCAM binding site of membrane-bound axonin-1, as suggested by the fact that four out of eight potential N-glycosylation sites conserved among axonin-1 and its mammalian homologues are concentrated on the fifth and sixth Ig domain (Hasler et al., 1993) . In addition to deletions involving the fifth and sixth Ig domain, domain deletion mutant AFn4 was found to have increased NgCAM binding compared with wild-type axonin-1. Assuming a stabilization of the backfolded shape by an intramolecular interaction near to the membrane, e.g. by a physical association of the first Ig and the fourth FNIII domain, the increased NgCAM binding by the axonin-1 mutant AFn4 could be ascribed to a destabilization of the backfolded shape resulting in an improved accessibility of the NgCAM binding site. A stabilization of the backfolded shape by an intramolecular interaction of axonin-1 is also suggested by the electron micrographs. In contrast to NCAM (Becker et al., 1989) and ICAM-l (Staunton et al., 1990) , electron micrographs of axonin-1 revealed only little segmental flexibility.
The electron micrographs of axonin-1 at the presently available resolution support the backfolded shape but do not allow a more detailed description of the tertiary structure of axonin-1. In particular, it is important to note that the structural features of the detailed domain arrangement of axonin-1 as depicted in Figure 9 are based on the NgCAM binding site mapping by axonin-1 domain deletion mutants and on the epitope mapping of antiaxonin-1 mAbs.
A reconsideration of the molecular interaction involved in neurite outgrowth on axonin-1 substratum A major conclusion drawn from the membrane-proximal location of the NgCAM binding site of axonin-1 might be that axonin-1 and NgCAM interact in the plane of the same membrane (in cis) rather than across the intermembrane space (in trans). This prediction is supported by several independent observations. (i) When TAG-I and L 1, the putative rodent homologues of axonin-1 and NgCAM, were expressed on the surface of Drosophila Schneider 2 cells, no interaction in trans occurred, as indicated by the observation that the cells did not form mixed aggregates (Felsenfeld et al., 1994) . (ii) Evidence for an interaction of axonin-1 and NgCAM in cis is derived from observations of co-clustering (Stoeckli et al, 1993) and cross-linking (S.Kunz and P.Sonderegger, in preparation) of axonin-1 and NgCAM in the plane of the same membrane. (iii) Neurite outgrowth studies in the presence of anti-axonin-1 mAbs that interfere with NgCAM binding and on truncated forms of axonin-1 show that the neurite outgrowth-promoting activity of axonin-1 substratum is not mediated by an axonin-I-NgCAM interaction in trans.
As determined by the neunte outgrowth studies on truncated forms of axonin-1, the growth cone receptor for axonin-1 substratum binds axonin-1 in a region distal to the four amino-terminal Ig domains that form the NgCAM binding site. Candidates for this axonin-1 receptor include the currently identified axonin-1 ligands, namely axonin-1 itself (Rader et al., 1993) and NrCAM/Bravo (Suter et al., 1995) . In addition, an c43I integrin was reported to be involved in neurite outgrowth on TAG-I substratum (Felsenfeld et al., 1994) . The fact that polyclonal antibodies directed to L1/NgCAM interfere with neurite outgrowth on TAG-I/axonin-1 substratum (Kuhn et al., 1991; Felsenfeld et al., 1994) suggests that neuronal LI/NgCAM is involved in neurite outgrowth on TAG-1/axonin-1 substratum. On the one hand, we cannot exclude the possibility that polyclonal antibodies binding to Lu/ NgCAM trigger an intracellular signal that reverses the signal induced by TAG-1/axonin-1 substratum; indeed, it is known that polyclonal and at least one monoclonal antibody directed to LI are capable of triggering intracellular signals (Appel et al., 1995) . On the other hand, it is conceivable that neuronal LI/NgCAM is directly involved in neurite outgrowth on TAG-1/axonin-1 substratum by an interaction in cis with the neuronal receptor of adsorbed TAG-1/axonin-1. Networks of molecules interconnected in the plane of the membrane and across the intermembrane space have been proposed as powerful means of regulating the growth and the guidance of axons during neurogenesis (Sonderegger and Rathjen, 1992) . The elucidation of the domain arrangement and the mapping of the binding sites of the participating molecules provides a basis for future investigations of the molecular composition and structure of these networks.
Materials and methods

Materials
Native axonin-I was purified from the vitreous fluid of 14-day-old chicken embryos (Ruegg et al., 1989) . NgCAM was isolated from 14-day-old chicken brain membranes by immunoaffinity chromatography using an anti-NgCAM mAb provided by Dr F.G.Rathjen (Rathjen et al., 1987) . Goat and rabbit polyclonal and mouse monoclonal antibodies against axonin-1 were raised as previously described (Ruegg et al., 1989) . IgG and Fab were obtained as previously specified (Stoeckli et al., 199 1) .
Construction of axonin-1 deletion mutants A 2.2 kb Sacl-HindIll fragment, a 1.7 kb EcoRI-HindIll fragment, a 0.6 kb BamHI-HindIII fragment and a 1.1 kb HindIll fragment were isolated from the axonin-I expression vector pMAX which contains the entire coding region of the axonin-l cDNA (Rader et al., 1993) . The fragments were cloned into the phagemid vector pTZ19U (Bio-Rad Laboratories, Richmond, CA) generating pTZI9U/axS-H, pTZ19U/ axE-H, pTZ19U/axB-H and pTZ19U/axH-H, respectively. pTZ19U/axB-H-H was generated by cloning the 1.1-kb HindIII fragment into pTZI 9U/ axB-H. Uracil-containing single strand DNA as a template for in vitro mutagenesis was obtained by using the Escherichia coli strain CJ 236 (Bio-Rad) and the helper phage VCSM1 3 (Stratagene, La Jolla, CA) as described (Yuckenberg et al., 1991) . The 10 single domain deletions were made by loop-out oligonucleotide-directed mutagenesis using the following oligonucleotides: CRAIgl, 5'-TCTGGTGCCAAGCACAGAGTGGCGGCTl-TTTGCAGGAATTCTCTGCAG-3'; CRAIg2, 5'-GGG-AAGCATCCCTCCGCTTTGGCGACGCCAGGCAGTATGCACCCAG-3'; CRAIg3, 5'-CCAGCTCAGCCTGGCTGCCGAGGCTCAGCCGG-ACTGGCTGGATG-3'; CRAIg4, 5'-TACCAGGGCCGCATCATCATT-CACGCCTTAGCACCAGATTTTAGACTAAAC-3'; CRAIg5, 5'-CAA-Fn4 and the sequence responsible for GPI anchorage. In vitro mutagenesis was performed as described above using pTZ19U/axS-H as a template for CREl, pTZ19U/axE-H for CRE2, CRE3 and CRE4, and pTZI9U/ axH-H for CRE/GPI. By use of the generated EcoRI sites in addition to the natural EcoRI site at the Igl/Ig2 border, the deletion mutants AIgl2, AIg23, AIg34, AIg1234 and Igl234 were generated by depletion of the respective EcoRI fragments. Due to the EcoRI insertions, the latter constructs led to conservative amino acid substitutions (see below). All deletion mutants were verified by double-strand DNA sequencing and cloned into the expression vector pSCT-axonin-I which drives the axonin-1 expression under the cytomegalovirus promoter and contains an SV40 origin of replication. To generate the double deletions AIg51, AIg52, AIg53, AIg5Fn1, AIg5Fn2, AIg5Fn3, AIg5Fn4, AIg6l, AIg62, AIg63, AIg64, AIg6Fn2, AIg6Fn3 and AIg6Fn4, single deletions were combined by substituting appropriate restriction fragments. Neighboured double domain deletions were generated as follows and verified by double-strand DNA sequencing: AIg54 by ligation of BclI at the beginning of the Ig4 coding region to BamHI at the end of IgS using pSCT-axonin-I produced in the dam-Ecoli strain GM33; AIg56 by ligation of EcoRV at the beginning of Ig6 to SmaI at the beginning of Fn using pSCTaxonin-l/Alg5; and AIg6FnI by ligation of SinaI at the beginning of Fnl to Klenow-treated HindIII at the end of Fnl using pSCT-axonin-I/AIg6.
Summary of the obtained mutants by their amino acid variation compared with wild-type axonin-I (Zuellig et al., 1992) : AIg I A(M27-F124);AIg2 = A(F126-E227);AIg3 = A(D228-H319);AIg4 A(A320-Q408); AIgS = A(L410-R501); AIg6 = A(D502-S594); AFn = A(P603-P705); AFn2 = A(T706-P807); AFn3 = A(K808-P908); AFn4 = A(P907-G 1001); AIg 12 = A(M27-F 124; S 131 -A229); AIg23 = A(S 131 -W324); AIg34 = A(A229-A409), D228E, L41OF; AIg1234 = A(M27-F124; S13 1-L410); Ig1234 = A(A409-A992), V994F; AIg5l = A(M27-F124; L410-R501); AIg52 = A(F126-E227; L410-R501); AIg53 = A(D228-H319; L410-R501); AIg54 = A(T329-G496); AIg56 = A(L410-R501; 1515-P603); AIg5FnI = A(L410-R501; P603-P705); AIg5Fn2 = A(L410-R501; T706-P807); AIg5Fn3 = A(L410-R501; K808-P908); AIg5Fn4 = A(L410-R501; P907-GIO01); AIg6l A(M27-F124; D502-S594); AIg62 = A(F126-E227; D502-S594); AIg63 = A(D228-H319; D502-S594); AIg64 = A(A320-Q408; D502-S594); AIg6Fn1 = A(D502-S594; G604-P691); AIg6Fn2 = A(D502-S594; T706-P807); AIg6Fn3 = A(D502-S594; K808-P908); AIg6Fn4 = A(D502-S594; P907-G1001).
Transfection of COS-1 cells
Transient transfectants were obtained by electroporation according to Chu et al. (1987) and Rols et al. (1994) . In brief, 106 trypsinized COS-l cells were resuspended in 700 ,tl of phosphate-buffered saline (PBS; 137 mM NaCI, pH 7.4, 3 mM KC1, 8 mM Na2HPO4, 1.5 mM KH2PO4) and mixed with 100 .tl of PBS containing 10 ,ug of CsCI-purified vector DNA. After a 10 min incubation on ice, electroporation was carried out in a 1 cm cuvette by applying 960 gF and 230 V (Bio-Rad Gene Pulser).
Post-incubation was for 10 min at 37°C. Then, the cells were cultured on 28 cm2 cell culture dishes in 5 ml of Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) at 370C in 5% CO2. After 7 h, the cells were washed twice with PBS and incubated overnight with 10 ml of DMEM, 10% FCS.
For immunoblotting the cells were washed twice with PBS and detached by treatment with 2 mM EDTA in PBS 2 days after transfection. For solubilization of membrane proteins, detached cells were sonicated with 10 pulses (20 W. I s) using a microtip sonifier (Branson Sonic Power Co., Danbury, CT). The membranes were sedimented by ultracentrifugation at 200 000 g for 20 min at 4°C and solubilized with 2% SDS. Immunoblotting was performed using 10 jil of solubilized membranes corresponding to i104 COS cells per lane. For comparison, 5 jil of vitreous fluid of 14-day-old chicken embryos was blotted.
Immunodetection was carried out with mixtures of four mouse monoclonal antibodies against axonin-1 and goat anti-mouse IgG conjugated to peroxidase (Kirkegaard & Perry Laboratories, Inc., Gaithersburg. MD) at a dilution of 1:1000.
Binding of NgCAM-coated Covaspheres to transfected COS-1 cells and immunofluorescence staining One day after transfection, cells were washed twice with PBS. detached by treatment with 2 mM EDTA in PBS, and resuspended in DMEM, 10% FCS. The cells were cultured overnight on polylysine-coated glass Lab-Tek slides (Nunc Inc., Naperville. IL) at 37°C in 5% CO2. Two days after transfection, the cells were washed twice with DMEM.
5 mg/ml bovine serum albumin (BSA). NgCAM-coated tetramethylrhodamine isothiocyanate (TRITC) Covaspheres (Kuhn et al., 1991) were sonicated for 2 min, diluted 1:1000 in DMEM, 5 mg/ml BSA and again sonicated for 3 min immediately before use. The cells were incubated with the prepared Covaspheres for I h at 37°C in 5%k CO,. washed twice with DMEM, 5 mg/ml BSA, and fixed with 2% formaldehyde (Fluka Chemie AG, Buchs, Switzerland) for I h at 37°C.
After washing twice with PBS, 1% FCS, axonin-I-expressing cells were detected by indirect immunofluorescence staining using goat antiserum raised against axonin-(1:l1000 dilution) and fluorescein isothiocyanate (FITC)-conjugated rabbit anti-goat IgG (1:1)00 dilution; Zymed Laboratories Inc., South San Francisco, CA). The preparation was examined Myeloma-based production of soluble axonin-1 variants For wild-type-Ck, the cDNA fragment CR2F-HB3 was amplified by PCR using the full-length axonin-l cDNA clone d-509 as a template (Zuellig et al., 1992) and the primer pair CR2F (Rader et al., 1993) and HB3 (5'-GCCAAGCTTACTTACCTCCACTGTTTCGGACGATG-3'). PCR amplification was performed as previously described (Rader et al., 1993) . CR2F-HB3 was digested with HindIll and used to substitute the HindIlI fragment of the axonin-I coding region in pMAX (Rader et ail., 1993) . This substitution fused the axonin-l coding region to the exon encoding the Ig-K constant region (Ig CK). For a vector map of pMAX which is derived from pCD4-FvCD3-C, (Traunecker et al.. 1991b ) see Rader et al. (1993) .
For AIgl234-C, the axonin-I deletion mutant AIgl234 was cloned into pMAX generating pMAX/AIg1234. HindIll-digested CR2F-HB3 was cloned into pMAX/Algl234 as described for wild-type-C,.
For IgI234-Ck, a Sad site was introduced at the Ig4/Ig5 border by oligonucleotide-directed mutagenesis using pTZ19U/axS-H (see above) as a template for the oligonucleotide CRS4 (5'-GCTGAATTAACA-GTGGGAGCTCTAGCACCAGATTTTAG-3'). A Q408G amino acid substitution resulted from the SacI insertion. The SacdI fragment that encodes the start codon, the signal peptide and the four amino-terminal Ig domains of axonin-I was cloned into Sacl-digested pMAX, thereby substituting the entire axonin-1 coding region and fusing the four aminoterminal Ig domains to Ig C,.
The integrity of the three constructs was confirmed by double-strand DNA sequencing. Stable transfectants were obtained by transfecting the constructs into the mouse myeloma cell line J558L by protoplast fusion (Oi et al., 1983) . Selection and screening of transfected myeloma cells was done as previously described (Rader et al.. 1993 Neurite outgrowth assay Native axonin-and axonin-variants at a concentration of 75 Pg/ml were adsorbed directly to tissue culture plastic (Nunclon; Nunc) for 2 h at 37°C. After washing with PBS. the tissue culture plastic was blocked for 30 min at 37°C with 10 mg/ml ovalbumin and washed auain with PBS. Dissociated dorsal root ganglion neurons from 10-day-old chicken embryos were plated at a density of 70 000 cells/10 cm2 and cultivated for 22 h in serum-free medium as specified previously (Stoeckli et al.. 1991) . For antibody perturbation tests. Fab of monoclonal mouse antiaxonin-lG and Fab of polyclonal goat anti-axonin-I IgG were added to a final concentration of 30 and 300 pg/ml. respectively. After 22 h in culture, the cells were fixed by addition of glutaraldehyde to a final concentration of 2cc. Quantification of neurite outgrowth was performed as described by Venstrom and Reichardt (1995) . Cells with neurites longer than two cell body diameters were scored as cells with neurites and 100 cells were scored for each condition.
Electron microscopy
Axonin-I molecules were adsorbed on glow-discharged C-coated EM grids by placing the grids with the C-film facing down on 5 ,ul drops of a 75 utg/ml dilution of native axonin-l in 20 mM NaP. pH 7.3. After 60 s. the excess liquid was removed and the immobilized molecules stained for 30 s with two sequentially applied drops of 2C/% uranyl acetate. Finally, excess stain was blotted off with filter paper. After air drying. the grids were examined in a Philips CM 12 transmission electron microscope operating at 100 kV acceleration voltage. Micrographs were taken with a Gatan G94 Slow Scan CCD camera under low dose conditions at a magnification of 60 000 and at -500 nm underfocus.
The images were stored on an Apple Macintosh Quadra 950 computer and hard copies wvere made with a Tektronics IISD sublimation printer.
